Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,278 results for "Medical Malpractice Law & Strategy"...

Drug & Device News
April 02, 2014
Bellwether Trial Opening in Vaginal Mesh MDL <br>NuvaRing Settlement in the Works
New Jersey Case Study
April 02, 2014
There has been a lack of consistency in malpractice cases where the plaintiff has settled with one or more defendants, and then goes to trial against other defendants. However, a recently published New Jersey Law Division case has brought a measure of consistency to this issue.
New Jersey Manufacturers and Punitive Damages
April 02, 2014
As discussed in Part One of this article, New Jersey's Products Liability Act (Defective Product) (PLA), N.J. Stat. ' 2A:58C-5 (c) (2013), prevents injured plaintiffs seeking compensation from drug and device manufacturers from being awarded punitive damages. The statute, which in an earlier form was enacted in 2008, provides, in pertinent part:
NJ & CT News
February 27, 2014
What's happening in neighboring states.
Drug & Device News
February 27, 2014
Discussion of news and litigation.
Verdicts
February 27, 2014
Analysis of a recent notable ruling.
Med Mal News
February 27, 2014
Recent news items of importance.
Judicial Scrutiny of 'Other Insurance' Clauses
February 27, 2014
Conclusion of a discussion of the ways in which different jurisdictions treat "excess insurance" clauses ' those that describe an insurer's obligation when more than one insurance policy provides coverage to the same insured for the same loss.
OCD: Beware Misdiagnosis
February 27, 2014
In the case of the diagnosis of "obsessive compulsive disorder" (OCD), a misdiagnosis may send the patient down the wrong treatment path entirely.
New Jersey Manufacturers and Punitive Damages
February 27, 2014
The state of New Jersey is home to the headquarters of 17 of the top 20 drug-producing companies in the world. These include pharmaceuticals producers Wyeth, Merck and Co. and Johnson &amp; Johnson.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›
  • Meet the Lawyer Working on Inclusion Rider Language
    At the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers &amp; Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.
    Read More ›